News
All news from Vismederi Holding
New scientific publication: “High-dose influenza vaccine: enhanced protection for the elderly”
A new scientific paper authored by Emanuele Montomoli and Claudia Maria Trombetta has just been published in Expert Review of Vaccines: “High-dose influenza vaccine: enhanced protection for the elderly.” The review highlights the added value of the high-dose...
VisMederi America: a new chapter in the Group’s international growth
VisMederi is pleased to announce the establishment of VisMederi America, a new company based in Cleveland that marks a strategic milestone in the Group’s expansion into the United States. The new entity aims to strengthen VisMederi’s international presence,...
VisMederi in the Sole 24 Ore ranking: recognized growth and international development
VisMederi is once again included in the "Leader of Growth 2026" ranking compiled by Il Sole 24 Ore in collaboration with Statista, where it ranks among the Italian companies that have performed the best in terms of revenue growth and development over the reference...
Development and Qualification of the Shigella Multiplex Assay: New Publication Highlights Major Collaborative Milestone
A new milestone in bacterial vaccine research: after several years of intensive research, validation work, and cross-institutional collaboration, the study on the development and qualification of a Multiplex assay for Shigella has now been officially published on...
VisMederi contributes to Clover Biopharmaceuticals’ advancement in innovative respiratory combination vaccines
We are proud to be part of Clover Biopharmaceuticals’ important achievement in advancing innovative respiratory combination vaccines. VisMederi contributed to the RSV+hMPV±PIV3 Combination Vaccines Phase I study by performing serological analyses, supporting the...
VisMederi at the 10th ESWI Influenza Conference in Valencia
VisMederi continues to strengthen its engagement in metapneumovirus control and vaccine research, confirming its active role in the international scientific community. At the 10th ESWI Influenza Conference, held in Valencia from 20 to 23 October 2025, Maria...